Skip to content

Opening book details…

About this Medicine article

913 USING SHORT-TERM MONOTHERAPY AND IN VITRO DATA TO MAKE EARLY PREDICTIONS OF CLINICAL HCV RESPONSE: EXAMPLES FROM MK-5172, A SECOND GENERATION HCV NS3/4A PROTEASE INHIBITOR by R.B. Nachbar; J.A. Stone; A. Petry; B. Poland; L. Caro; L.A. Wenning; A. Khan; J. Palcza; K. Van Dyck; I. Fraser; N. Mobashery; E. O'Mara is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
R.B. Nachbar; J.A. Stone; A. Petry; B. Poland; L. Caro; L.A. Wenning; A. Khan; J. Palcza; K. Van Dyck; I. Fraser; N. Mobashery; E. O'Mara
Publisher
Elsevier Science; Elsevier ; Elsevier BV; Wiley (ISSN 0168-8278)
Published
2012
Language
EN
Field
Medicine (Health Sciences)

More by R.B. Nachbar; J.A. Stone; A. Petry; B. Poland; L. Caro; L.A. Wenning; A. Khan; J. Palcza; K. Van Dyck; I. Fraser; N. Mobashery; E. O'Mara

Browse all works by R.B. Nachbar; J.A. Stone; A. Petry; B. Poland; L. Caro; L.A. Wenning; A. Khan; J. Palcza; K. Van Dyck; I. Fraser; N. Mobashery; E. O'Mara